{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:30:10Z","timestamp":1793125810892,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NIH\/NCI Cancer Center Support Grant","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]},{"DOI":"10.13039\/100009933","name":"Ethicon","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009933","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-025-11973-8","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T12:31:11Z","timestamp":1758112271000},"page":"2295-2304","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Outcomes following microwave ablation of 669 primary and metastatic lung malignancies"],"prefix":"10.1007","volume":"36","author":[{"given":"Ruben","family":"Geevarghese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica S.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elsakka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Chevallier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlasios S.","family":"Sotirchos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos T.","family":"Sofocleous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena N.","family":"Petre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Erinjeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fourat","family":"Ridouani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna Nand","family":"Keshavamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Salkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hooman","family":"Yarmohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3188-0085","authenticated-orcid":false,"given":"Etay","family":"Ziv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"key":"11973_CR1","doi-asserted-by":"publisher","first-page":"340","DOI":"10.6004\/jnccn.2023.0020","volume":"21","author":"DS Ettinger","year":"2023","unstructured":"Ettinger DS, Wood DE, Aisner DL et al (2023) NCCN guidelines\u00ae insights: non\u2013small cell lung cancer, version 2.2023: featured updates to the NCCN guidelines. J Natl Compr Canc Netw 21:340\u2013350. https:\/\/doi.org\/10.6004\/jnccn.2023.0020","journal-title":"J Natl Compr Canc Netw"},{"key":"11973_CR2","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.3390\/cancers13205202","volume":"13","author":"M Ghosn","year":"2021","unstructured":"Ghosn M, Solomon SB (2021) Current management of oligometastatic lung cancer and future perspectives: results of thermal ablation as a local ablative therapy. Cancers (Basel) 13:5202. https:\/\/doi.org\/10.3390\/cancers13205202","journal-title":"Cancers (Basel)"},{"key":"11973_CR3","doi-asserted-by":"publisher","unstructured":"Benson AB, Hunt S, Parikh A (2024) NCCN clinical practice guidelines in oncology (NCCN guidelines\u00ae) colon cancer version 3.2024. J Natl Compr Canc Netw 22:e240029. https:\/\/doi.org\/10.6004\/jnccn.2024.0029","DOI":"10.6004\/jnccn.2024.0029"},{"key":"11973_CR4","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.4103\/jcrt.jcrt_2048_23","volume":"19","author":"Z Li","year":"2023","unstructured":"Li Z, Zhao F, Wang G et al (2023) Changes in the pulmonary function of CT-guided microwave ablation for patients with malignant lung tumors. J Cancer Res Ther 19:1669\u20131674. https:\/\/doi.org\/10.4103\/jcrt.jcrt_2048_23","journal-title":"J Cancer Res Ther"},{"key":"11973_CR5","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1148\/rg.2018170155","volume":"38","author":"JA Febbo","year":"2018","unstructured":"Febbo JA, Gaddikeri RS, Shah PN (2018) Stereotactic body radiation therapy for early-stage non\u2013small cell lung cancer: a primer for radiologists. Radiographics 38:1312\u20131336. https:\/\/doi.org\/10.1148\/rg.2018170155","journal-title":"Radiographics"},{"key":"11973_CR6","doi-asserted-by":"publisher","first-page":"e2020002","DOI":"10.23750\/abm.v91i10-S.10342","volume":"91","author":"P Mendogni","year":"2020","unstructured":"Mendogni P, Daffr\u00e8 E, Rosso L et al (2020) Percutaneous lung microwave ablation versus lung resection in high-risk patients. A monocentric experience. Acta Biomed 91:e2020002. https:\/\/doi.org\/10.23750\/abm.v91i10-S.10342","journal-title":"Acta Biomed"},{"key":"11973_CR7","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1080\/02656736.2018.1434901","volume":"34","author":"W Yao","year":"2018","unstructured":"Yao W, Lu M, Fan W et al (2018) Comparison between microwave ablation and lobectomy for stage I non-small cell lung cancer: a propensity score analysis. Int J Hyperth 34:1329\u20131336. https:\/\/doi.org\/10.1080\/02656736.2018.1434901","journal-title":"Int J Hyperth"},{"key":"11973_CR8","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/j.jvir.2023.06.014","volume":"34","author":"J-Z Peng","year":"2023","unstructured":"Peng J-Z, Wang C-E, Bie Z-X et al (2023) Microwave ablation for inoperable stage I non\u2013small cell lung cancer in patients aged \u226570 years: a prospective, single-center study. J Vasc Interv Radiol 34:1771\u20131776. https:\/\/doi.org\/10.1016\/j.jvir.2023.06.014","journal-title":"J Vasc Interv Radiol"},{"key":"11973_CR9","doi-asserted-by":"publisher","first-page":"100454","DOI":"10.1016\/j.jtocrr.2022.100454","volume":"4","author":"SM Chan","year":"2023","unstructured":"Chan SM, Julien PJ, Kaganjo P et al (2023) Safety and efficacy outcomes from a single-center study of image-guided percutaneous microwave ablation for primary and metastatic lung malignancy. JTO Clin Res Rep 4:100454. https:\/\/doi.org\/10.1016\/j.jtocrr.2022.100454","journal-title":"JTO Clin Res Rep"},{"key":"11973_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-017-0946-x","volume":"34","author":"M Macchi","year":"2017","unstructured":"Macchi M, Belfiore MP, Floridi C et al (2017) Radiofrequency versus microwave ablation for treatment of the lung tumours: LUMIRA (lung microwave radiofrequency) randomized trial. Med Oncol 34:96. https:\/\/doi.org\/10.1007\/s12032-017-0946-x","journal-title":"Med Oncol"},{"key":"11973_CR11","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.21873\/anticanres.16461","volume":"43","author":"CQY Tan","year":"2023","unstructured":"Tan CQY, Ho A, Robinson HA et al (2023) A systematic review of microwave ablation for colorectal pulmonary metastases. Anticancer Res 43:2899\u20132907. https:\/\/doi.org\/10.21873\/anticanres.16461","journal-title":"Anticancer Res"},{"key":"11973_CR12","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1148\/radiol.2473070996","volume":"247","author":"FJ Wolf","year":"2008","unstructured":"Wolf FJ, Grand DJ, Machan JT et al (2008) Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients. Radiology 247:871\u2013879. https:\/\/doi.org\/10.1148\/radiol.2473070996","journal-title":"Radiology"},{"key":"11973_CR13","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/jso.23701","volume":"110","author":"X Yang","year":"2014","unstructured":"Yang X, Ye X, Zheng A et al (2014) Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases. J Surg Oncol 110:758\u2013763. https:\/\/doi.org\/10.1002\/jso.23701","journal-title":"J Surg Oncol"},{"key":"11973_CR14","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1007\/s00270-018-2000-6","volume":"41","author":"I Kurilova","year":"2018","unstructured":"Kurilova I, Gonzalez-Aguirre A, Beets-Tan RG et al (2018) Microwave ablation in the management of colorectal cancer pulmonary metastases. Cardiovasc Interv Radiol 41:1530\u20131544. https:\/\/doi.org\/10.1007\/s00270-018-2000-6","journal-title":"Cardiovasc Interv Radiol"},{"key":"11973_CR15","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jvir.2016.10.030","volume":"28","author":"TT Healey","year":"2017","unstructured":"Healey TT, March BT, Baird G, Dupuy DE (2017) Microwave ablation for lung neoplasms: a retrospective analysis of long-term results. J Vasc Interv Radiol 28:206\u2013211. https:\/\/doi.org\/10.1016\/j.jvir.2016.10.030","journal-title":"J Vasc Interv Radiol"},{"key":"11973_CR16","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s11547-022-01508-2","volume":"127","author":"RF Grasso","year":"2022","unstructured":"Grasso RF, Bernetti C, Pacella G et al (2022) A comparative analysis of thermal ablation techniques in the treatment of primary and secondary lung tumors: a single-center experience. Radiol Med 127:714\u2013724. https:\/\/doi.org\/10.1007\/s11547-022-01508-2","journal-title":"Radiol Med"},{"key":"11973_CR17","doi-asserted-by":"publisher","first-page":"1241.e1","DOI":"10.1016\/j.jvir.2021.04.024","volume":"32","author":"SJ Genshaft","year":"2021","unstructured":"Genshaft SJ, Suh RD, Abtin F et al (2021) Society of Interventional Radiology multidisciplinary position statement on percutaneous ablation of non-small cell lung cancer and metastatic disease to the lungs. J Vasc Interv Radiol 32:1241.e1\u20131241.e12. https:\/\/doi.org\/10.1016\/j.jvir.2021.04.024","journal-title":"J Vasc Interv Radiol"},{"key":"11973_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1148\/radiol.14132958","volume":"273","author":"M Ahmed","year":"2014","unstructured":"Ahmed M, Solbiati L, Brace CL et al (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria\u2014a 10-year update. Radiology 273:241\u2013260. https:\/\/doi.org\/10.1148\/radiol.14132958","journal-title":"Radiology"},{"key":"11973_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jvir.2022.10.011","volume":"34","author":"MO Baerlocher","year":"2023","unstructured":"Baerlocher MO, Nikolic B, Sze DY (2023) Adverse event classification: clarification and validation of the Society of Interventional Radiology specialty\u2013specific system. J Vasc Interv Radiol 34:1\u20133. https:\/\/doi.org\/10.1016\/j.jvir.2022.10.011","journal-title":"J Vasc Interv Radiol"},{"key":"11973_CR20","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1016\/j.jvir.2016.08.013","volume":"27","author":"A Zheng","year":"2016","unstructured":"Zheng A, Ye X, Yang X et al (2016) Local efficacy and survival after microwave ablation of lung tumors: a retrospective study in 183 patients. J Vasc Interv Radiol 27:1806\u20131814. https:\/\/doi.org\/10.1016\/j.jvir.2016.08.013","journal-title":"J Vasc Interv Radiol"},{"key":"11973_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.25259\/JCIS_224_2020","volume":"11","author":"M Nance","year":"2021","unstructured":"Nance M, Khazi Z, Kaifi J et al (2021) Computerized tomography-guided microwave ablation of patients with stage I non-small cell lung cancers: a single-institution retrospective study. J Clin Imaging Sci 11:7. https:\/\/doi.org\/10.25259\/JCIS_224_2020","journal-title":"J Clin Imaging Sci"},{"key":"11973_CR22","doi-asserted-by":"publisher","first-page":"943715","DOI":"10.3389\/fonc.2022.943715","volume":"12","author":"Y Han","year":"2022","unstructured":"Han Y, Yan X, Zhi W et al (2022) Long-term outcome following microwave ablation of lung metastases from colorectal cancer. Front Oncol 12:943715. https:\/\/doi.org\/10.3389\/fonc.2022.943715","journal-title":"Front Oncol"},{"key":"11973_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1148\/radiol.2016160003","volume":"282","author":"E Ziv","year":"2017","unstructured":"Ziv E, Erinjeri JP, Yarmohammadi H et al (2017) Lung adenocarcinoma: predictive value of KRAS mutation status in assessing local recurrence in patients undergoing image-guided ablation. Radiology 282:251\u2013258. https:\/\/doi.org\/10.1148\/radiol.2016160003","journal-title":"Radiology"},{"key":"11973_CR24","doi-asserted-by":"publisher","first-page":"107259","DOI":"10.1016\/j.lungcan.2023.107259","volume":"182","author":"P Laeseke","year":"2023","unstructured":"Laeseke P, Ng C, Ferko N et al (2023) Stereotactic body radiation therapy and thermal ablation for treatment of NSCLC: a systematic literature review and meta-analysis. Lung Cancer 182:107259. https:\/\/doi.org\/10.1016\/j.lungcan.2023.107259","journal-title":"Lung Cancer"},{"key":"11973_CR25","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3892\/ol.2024.14455","volume":"28","author":"T Dong","year":"2024","unstructured":"Dong T, Fan H, Lyu J et al (2024) A retrospective study comparing the efficacy of microwave ablation and stereotactic body radiotherapy in colorectal cancer lung metastases. Oncol Lett 28:322. https:\/\/doi.org\/10.3892\/ol.2024.14455","journal-title":"Oncol Lett"},{"key":"11973_CR26","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.1007\/s00330-020-07634-7","volume":"31","author":"MV Chan","year":"2021","unstructured":"Chan MV, Huo YR, Cao C, Ridley L (2021) Survival outcomes for surgical resection versus CT-guided percutaneous ablation for stage I non-small cell lung cancer (NSCLC): a systematic review and meta-analysis. Eur Radiol 31:5421\u20135433. https:\/\/doi.org\/10.1007\/s00330-020-07634-7","journal-title":"Eur Radiol"},{"key":"11973_CR27","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.21037\/jtd-24-557","volume":"16","author":"S-P Cui","year":"2024","unstructured":"Cui S-P, Zhao Q, Wang J et al (2024) Exploring the impact of variable power outputs on the efficacy and safety during microwave ablation for lung carcinoma: a real-world study. J Thorac Dis 16:5031\u20135041. https:\/\/doi.org\/10.21037\/jtd-24-557","journal-title":"J Thorac Dis"},{"key":"11973_CR28","doi-asserted-by":"publisher","first-page":"153303382311852","DOI":"10.1177\/15330338231185277","volume":"22","author":"C Lanza","year":"2023","unstructured":"Lanza C, Carriero S, Ascenti V et al (2023) Percutaneous application of high power microwave ablation with 150\u2009W for the treatment of tumors in lung, liver, and kidney: a preliminary experience. Technol Cancer Res Treat 22:15330338231185277. https:\/\/doi.org\/10.1177\/15330338231185277","journal-title":"Technol Cancer Res Treat"},{"key":"11973_CR29","doi-asserted-by":"publisher","first-page":"e0162634","DOI":"10.1371\/journal.pone.0162634","volume":"11","author":"SM Thompson","year":"2016","unstructured":"Thompson SM, Callstrom MR, Jondal DE et al (2016) Heat stress-induced PI3K\/mTORC2-dependent AKT signaling is a central mediator of hepatocellular carcinoma survival to thermal ablation induced heat stress. PLoS One 11:e0162634. https:\/\/doi.org\/10.1371\/journal.pone.0162634","journal-title":"PLoS One"},{"key":"11973_CR30","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jvir.2016.11.042","volume":"28","author":"Q Yang","year":"2017","unstructured":"Yang Q, Qi H, Zhang R et al (2017) Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: evaluation based on a review of 147 tumors. J Vasc Interv Radiol 28:481\u2013489. https:\/\/doi.org\/10.1016\/j.jvir.2016.11.042","journal-title":"J Vasc Interv Radiol"},{"key":"11973_CR31","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00270-017-1760-8","volume":"41","author":"S Gao","year":"2018","unstructured":"Gao S, Stein S, Petre EN et al (2018) Micropapillary and\/or solid histologic subtype based on pre-treatment biopsy predicts local recurrence after thermal ablation of lung adenocarcinoma. Cardiovasc Interv Radiol 41:253\u2013259. https:\/\/doi.org\/10.1007\/s00270-017-1760-8","journal-title":"Cardiovasc Interv Radiol"},{"key":"11973_CR32","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1080\/02656736.2022.2055795","volume":"39","author":"N Vasiniotis Kamarinos","year":"2022","unstructured":"Vasiniotis Kamarinos N, Gonen M, Sotirchos V et al (2022) 3D margin assessment predicts local tumor progression after ablation of colorectal cancer liver metastases. Int J Hyperth 39:880\u2013887. https:\/\/doi.org\/10.1080\/02656736.2022.2055795","journal-title":"Int J Hyperth"},{"key":"11973_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-021-00626-z","volume":"21","author":"P Yan","year":"2021","unstructured":"Yan P, Tong A, Nie X, Ma M (2021) Assessment of safety margin after microwave ablation of stage I NSCLC with three-dimensional reconstruction technique using CT imaging. BMC Med Imaging 21:96. https:\/\/doi.org\/10.1186\/s12880-021-00626-z","journal-title":"BMC Med Imaging"},{"key":"11973_CR34","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1477-2574.2012.00585.x","volume":"15","author":"RT Groeschl","year":"2013","unstructured":"Groeschl RT, Wong RK, Quebbeman EJ et al (2013) Recurrence after microwave ablation of liver malignancies: a single institution experience. HPB (Oxford) 15:365\u2013371. https:\/\/doi.org\/10.1111\/j.1477-2574.2012.00585.x","journal-title":"HPB (Oxford)"},{"key":"11973_CR35","doi-asserted-by":"crossref","unstructured":"Keshavamurthy KN, Eickhoff C, Ziv E (2024) Pre-operative lung ablation prediction using deep learning. Eur Radiol 34:7161\u20137172","DOI":"10.1007\/s00330-024-10767-8"},{"key":"11973_CR36","doi-asserted-by":"publisher","unstructured":"Ridouani F, Solomon SB, Bryce Y et al (2020) Predictors of progression-free survival and local tumor control after percutaneous thermal ablation of oligometastatic breast cancer: retrospective study. J Vasc Interv Radiol 31:1201\u20131209. https:\/\/doi.org\/10.1016\/j.jvir.2020.02.016","DOI":"10.1016\/j.jvir.2020.02.016"},{"key":"11973_CR37","doi-asserted-by":"crossref","unstructured":"Cooke TM, Sofocleous CT, Petre EN et al (2025) Microwave ablation of colorectal pulmonary metastases offers excellent local tumor control and prolongs time off chemotherapy. Cardiovasc Interv Radiol 48:769\u2013776","DOI":"10.1007\/s00270-025-04036-4"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11973-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-11973-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11973-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T13:20:08Z","timestamp":1772716808000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-11973-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["11973"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-11973-8","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,17]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Dr Etay Ziv.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare relationships with the following companies: Constantinos T. Sofocleous discloses grants or contracts from NIH\/NCI, SIRTEX, SIO, Boston Scientific, SIR Foundation, Varian, and Ethicon J & J. He received consulting fees from SIRTEX, Varian, and Ethicon J & J, honoraria from Ethicon J & J and Varian, and equipment or services from MIM Software. Hooman Yarmohammadi discloses a research grant from Guerbet LLC. Olivier Chevallier discloses a 1-year research fellowship grant from Soci\u00e9t\u00e9 Fran\u00e7aise de Radiologie (SFR) and Coll\u00e8ge des Enseignants de Radiologie de France (CERF). Joseph P. Erinjeri discloses consulting fees from AstraZeneca. Chenyang Zhan discloses grants or contracts from the Society of Interventional Radiology, MSK Cancer Center Support Grant, and K12 Grant. Erica Alexander discloses consulting fees from Boston Scientific and an unpaid leadership role with the Society of Interventional Oncology. Etay Ziv discloses research grants from MSKCC, AACR, SIR, NANETS, RSNA, Ethicon, Novartis, and TOW Center. Stephen B. Solomon discloses grants or contracts from GE Healthcare and Johnson & Johnson (institutional). He received consulting fees from GE Healthcare, Johnson & Johnson, Merck, Magnisity, and Obsidian (self). He participated on advisory boards for Candel Therapeutics and Impact Biotech (self) and serves on the board of directors for PAIGE AI. He also disclosed stock or stock options from Johnson & Johnson.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board (MSK IRB Protocol No: 16-402).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The current study overlaps with patients from prior publications. This includes (1) 72 patients who were part of a study evaluating deep learning in lung ablation zone prediction (Keshavamurthy et al [\n                      \n                      ]), (2) a study of 50 patients undergoing MWA for colorectal pulmonary metastases (Kurilova et al [\n                      \n                      ]), (3) 54 patients who were part of a study evaluating the role of KRAS mutation status and post-ablation recurrence (Ziv et al [\n                      \n                      ]), (4) 7 patients treated as part of a study evaluating lung ablation in breast cancer patients with oligometastatic disease (Ridouani et al [\n                      \n                      ]) and (5) 53 patients who were part of a study evaluating the role of lung histological subtype in post-ablation recurrence (Gao et al [\n                      \n                      ]). (6) Additionally, a study of 225 patients treated with microwave ablation for colorectal lung metastases (Cooke et al [\n                      \n                      ]). The current study not only includes a larger number of patients but also analyzes outcomes in relation to variables that were not previously assessed. The published papers have been uploaded with our manuscript submission.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}